Skip to Content
Merck
CN

243590

Potassium perrhenate

99%

Synonym(s):

Potassium oxido(trioxo)rhenium, Potassium tetraoxorhenate(1-)

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
KReO4
CAS Number:
Molecular Weight:
289.30
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
233-953-8
MDL number:
Assay:
99%
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

99%

form

powder

reaction suitability

core: potassium

refractive index

n20/D 1.643 (lit.)

mp

550 °C (lit.)

density

4.887 g/mL at 25 °C (lit.)

SMILES string

[K+].[O-][Re](=O)(=O)=O

InChI

1S/K.4O.Re/q+1;;;;-1;

InChI key

QFKRWIFGDGKWLM-UHFFFAOYSA-N

Application

The reduction of KReO4 in the preparation of cyclopentadienyltricarbonylrhenium complexes has potential as a model for the syntheses of technetium and rhenium organometallic radiopharmaceuticals.


Still not finding the right product?

Explore all of our products under Potassium perrhenate


Storage Class

5.1B - Oxidizing hazardous materials

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves, type P3 (EN 143) respirator cartridges



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Spradau, T.W. Katzenellenbogen, J.A.
Organometallics, 17, 2009-2009 (1998)
Yuee Feng et al.
Inorganic chemistry, 48(23), 11058-11066 (2009-11-06)
The detailed syntheses of complexes of the form [Re(O)(X)(RNCH(2)CH(2))(2)N(Me)] (X = Me, Cl, I, R = mesityl, C(6)F(5)), 1-3, incorporating diamidoamine ancillary ligands are described. X-ray crystal structures for the complexes [Re(O)(Me)((C(6)F(5))NCH(2)CH(2))(2)N(Me)], 1a, [Re(O)(I)((C(6)F(5))N CH(2)CH(2))(2)N(Me)], 3a, and [Re(O)(I)((Mes)NCH(2))(2)N(Me)], 3b, are
Mark J Bailey et al.
Advanced healthcare materials, 1(4), 437-442 (2012-11-28)
Configuring RE(2) O(3) nanocrystals with pseudo-2D morphologies confers substantive gains in relaxivities over equivalent spherical counterparts. The most promising arises from Gd(2) O(3) whose ionic transverse and longitudinal relaxivities were as high as r(1) = 12.7 mM(-1) s(-1) and r(2)



Global Trade Item Number

SKUGTIN
243590-5G04061832968537
243590-25G04061838138552